Co-crystals of sodium benzoate and uses thereof Grant US-11731928-B2 United States of America 22 Aug 2023
Acido chinico per l'uso nel trattamento dei disturbi dell'umore - Quinic acid for use in… N/A IT-202200000581-A1 Italy 17 Jul 2023
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC… Grant US-11472777-B2 United States of America 18 Oct 2022
4-[5-[(RAC)-1-[5-(3-CHLOROPHENYL)-3-ISOXAZOLYL]ETHOXY]-4-METHYL-4H-1,2,4-TRIAZOL-3-YL]PYRID… Application WO-2021089300-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10980758-B2 United States of America 20 Apr 2021
Methods for treating central nervous system disorders using vdac inhibitors Grant US-10946013-B2 United States of America 16 Mar 2021
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC… Grant US-10787423-B2 United States of America 29 Sep 2020
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10632091-B2 United States of America 28 Apr 2020
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10617663-B2 United States of America 14 Apr 2020
Cycloalkylamines as monoamine reuptake inhibitors Grant US-10562878-B2 United States of America 18 Feb 2020
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC… Grant US-10508091-B2 United States of America 17 Dec 2019
Methods for treating central nervous system disorders using VDAC inhibitors Grant US-10434099-B2 United States of America 08 Oct 2019
3BETA-(4-METHOXYBENZYLOXY)PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF CANNABINOIDS-RELATE… Application WO-2019162328-A1 World Intellectual Property Organisation (WIPO) 29 Aug 2019
Mitochondria-targeted antioxidants for treatment of age-related brain disorders Grant US-10188669-B2 United States of America 29 Jan 2019
Dosage forms and therapeutic uses L-4-chlorokynurenine Grant US-9993453-B2 United States of America 12 Jun 2018
Cycloalkylamines as monoamine reuptake inhibitors Grant US-9868718-B2 United States of America 16 Jan 2018
Pharmaceutical composition for use in medical and veterinary ophthalmology Grant US-9724313-B2 United States of America 08 Aug 2017
Oral formulations of mitochondrially-targeted antioxidants and their preparation and use Grant US-9572890-B2 United States of America 21 Feb 2017
Pharmaceutical compositions for preventing and treating eye pathologies Grant US-9572821-B2 United States of America 21 Feb 2017
Pharmaceutical compositions useful for preventing and treating cancer Grant US-9408859-B2 United States of America 09 Aug 2016
Pharmaceutical substances on the basis of mitochondria-addressed antioxidants Grant US-9233903-B2 United States of America 12 Jan 2016
Oral formulations of mitochondrially-targeted antioxidants and their preparation and use Grant US-9192676-B2 United States of America 24 Nov 2015
MITOCHONDRIA-TARGETED ANTIOXIDANTS FOR TREATMENT OF AGE-RELATED BRAIN DISORDERS Application WO-2013044058-A1 World Intellectual Property Organisation (WIPO) 28 Mar 2013
PSYCHO-PHARMACEUTICALS Application WO-2009128057-A2 World Intellectual Property Organisation (WIPO) 22 Oct 2009
PSYCHO-PHARMACEUTICALS Application WO-2009128058-A1 World Intellectual Property Organisation (WIPO) 22 Oct 2009